Thoracic Surgery (Cardiothoracic Vascular Surgery)
Audio Summaries

Tenecteplase Before Thrombectomy at 4.5 to 24 Hours for Basilar Artery Occlusion: The ATTENTION LATE Randomized Clinical Trial

The study aimed to determine whether intravenous tenecteplase administered before endovascular thrombectomy (EVT) improves outcomes in patients with moderate to severe basilar artery occlusion presenting 4.5 to 24 hours after stroke onset. The findings revealed no significant difference in functional independence or safety outcomes between the tenecteplase plus EVT group and the EVT alone group, suggesting that the addition of tenecteplase does not enhance recovery in this patient population.

Phase 1 Study of Anito-cel, a d-Domain BCMA CAR T Cell for Refractory or Recurrent Myeloma

This phase 1 study investigates the safety and efficacy of anitocabtagene autoleucel (anito-cel), a BCMA-directed CAR T-cell therapy, in patients with relapsed or refractory multiple myeloma who have undergone multiple prior treatments. The results indicate a high response rate (100%) with a significant proportion achieving complete response (79%), while adverse events, particularly cytokine release syndrome and neurotoxicity, were mostly mild. The findings suggest that anito-cel may be a promising treatment option for this challenging patient population.

Etuvetidigene Autotemcel for the Treatment of Wiskott-Aldrich Syndrome

This study investigates the efficacy and safety of etuvetidigene autotemcel (etu-cel), an autologous gene therapy, for treating Wiskott-Aldrich syndrome, a rare genetic disorder. The results indicate a high overall survival rate of 96% at both 1 and 5 years post-treatment, along with a significant reduction in severe infections and bleeding events after therapy. The findings suggest that etu-cel provides a sustained clinical benefit for patients with this condition.

Clinical Uses of Common Genetic Variants Associated with Common Diseases

The authors investigate why the integration of polygenic risk scores and genomic knowledge into clinical practice for common adult-onset diseases has been slow, despite advancements in genomics and the identification of numerous genetic variants associated with these conditions. They explore potential applications of these scores and pharmacogenomics in improving prevention and treatment strategies as genome sequencing becomes more accessible.

Effect of Screening with Multicancer Early-Detection Test on Late-Stage Cancer Diagnosis

The authors aimed to determine whether screening with a multicancer early-detection test, in addition to usual care, reduces the incidence of late-stage cancers (stage III or IV) compared to usual care alone. In a randomized controlled trial involving over 142,000 participants, they found no significant difference in the incidence rates of stage III or IV cancers between the two groups after three screening rounds. While there was a trend towards a lower incidence of stage IV cancers, the results were not conclusive, indicating the need for further follow-up.

Asb2-KIF11 Axis Protects Against Heart Failure by Restoring Lysosomal Distribution and Mitochondrial Homeostasis

The authors investigate the role of Asb2, a muscle-specific E3 ubiquitin ligase, in cardiac remodeling and heart failure, particularly its impact on mitochondrial function and autophagic flux. They find that Asb2 deficiency leads to cardiac hypertrophy and heart failure through impaired KIF11-mediated lysosomal distribution and autophagosome-lysosome fusion. Restoring Asb2 expression or inhibiting KIF11 can reverse these pathological changes, suggesting that targeting the Asb2-KIF11 axis may offer a therapeutic approach for chronic heart failure.

Prognostic Value of Coronary Computed Tomography Angiography-Derived Fractional Flow Reserve From a Large Nationwide Cohort

The authors aimed to investigate the prognostic value of coronary computed tomography angiography-derived fractional flow reserve (FFR-CT) in predicting future cardiovascular events in a large nationwide cohort over a three-year follow-up period. They found that lower FFR-CT values were significantly associated with increased risks of myocardial infarction, cardiovascular mortality, and all-cause mortality, with a threshold of 0.67 identified as optimal for predicting these outcomes. The study highlights the importance of FFR-CT measurements in assessing cardiovascular risk beyond traditional factors and stenosis severity.

Current advancements in the care of peripheral arterial disease: modern approaches to medical, endovascular, and surgical treatment

The authors review current advancements in the management of peripheral arterial disease (PAD), particularly focusing on the effectiveness of medical therapy, supervised exercise, and the judicious use of revascularization procedures. They aim to address how to optimize treatment strategies to reduce cardiovascular risks, improve quality of life, and minimize limb loss in patients with varying severity of PAD. The paper highlights the complexities of PAD management due to its multifaceted nature and the potential overuse of invasive interventions.

Novel mTORC1 Booster LAPTM4A Potentiates Pathological Cardiac Hypertrophy

The authors investigate the role of LAPTM4A, a lysosomal protein, in regulating mTORC1 signaling and its impact on pathological cardiac hypertrophy in cardiomyocytes. They find that LAPTM4A promotes hypertrophy and cardiac dysfunction by enhancing mTORC1-mediated protein synthesis, and its deletion mitigates hypertrophy in a mouse model. The study suggests that targeting the LAPTM4A-mTORC1 pathway could be a promising therapeutic strategy for treating cardiac hypertrophy.

Peripheral arterial disease: adverse impacts, disparities in outcomes, and the path ahead

This paper aims to address the adverse impacts of peripheral arterial disease (PAD) and the disparities in outcomes among affected populations. The authors highlight the significant individual and societal burdens of PAD, particularly on underserved groups, and propose both short-term and long-term strategies to improve management and access to care, including enhanced awareness and multidisciplinary treatment approaches. The study emphasizes the need for targeted interventions to reduce the prevalence and consequences of PAD, especially in vulnerable communities.